MKI67 and metastatic malignant neoplasm in the lymph nodes: Some doctors have proposed risk criteria for recurrence after SPN, including diffuse tumor growth, capsular involvement, vascular or perineural invasion, lymph node metastasis or distant metastasis, and a Ki-67 index ≥4% is associated with SPN recurrence.